We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FDA Supports SweetLeaf’s Glycoside Safety Claim

September 1, 2009: 05:47 AM EST
The U.S. Food & Drug Administration has signed off on the safety claims of the stevia-based artificial sweetener SweetLeaf. The agency granted the whole leaf steviol glycosides used in the product extract the Generally Recognized As Safe (GRAS) status. SweetLeaf, made from the stevia plant harvested in Central and South America and 300-350% sweeter than sugar, is marketed as a safe and pure alternative for weight-conscious consumers, and for food and beverage companies. The company says its brand not only substitutes well for sugar in recipes, it lacks the bitter aftertaste of competitor stevia sweeteners.
"U.S. Food & Drug Administration Issues “No Questions” Letter Supporting Safety Of SweetLeaf Sweetener®", NewsGuide.us, September 01, 2009, © NewsGuide.us
Food Safety
Policy & Regulation
North America
Latin America
United States of America
Companies, Organizations
Legal, Legislation, Regulation, Policy
Market News
Products & Brands
Developed by Yuri Ingultsov Software Lab.